Back to today’s briefing

Story perspectives

Rep. Bresnahan's Stock Sale Sparks Medicaid Trading Controversy

11/20/2025

26 3 Full Breakdown

Summary

Story summary

Rep. Rob Bresnahan (R-Pa.) sold up to $130,000 in stocks from companies that manage roughly half of Medicaid enrollees, shortly before voting for a bill that cut Medicaid funding by nearly $1 trillion.
His trades sparked scrutiny and calls to ban congressional stock trading.
The House is holding hearings on the issue with bipartisan criticism.
Rep. Anna Paulina Luna (R-Fla.) may push for a ban vote if progress stalls.

1 of 1

Story summary

Rep. Rob Bresnahan (R-Pa.) sold up to $130,000 in stocks from companies that manage roughly half of Medicaid enrollees, shortly before voting for a bill that cut Medicaid funding by nearly $1 trillion.
His trades sparked scrutiny and calls to ban congressional stock trading.
The House is holding hearings on the issue with bipartisan criticism.
Rep. Anna Paulina Luna (R-Fla.) may push for a ban vote if progress stalls.